Tyrosol



Compound IDCDAMM02100
Common nameTyrosol
IUPAC name4-(2-hydroxyethyl)phenol
Molecular formulaC8H10O2

Experimental data

Retention time8.6
Adduct[M+NH4]+
Actual mz156.101
Theoretical mz156.102
Error2.71
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.8407

Identifiers and class information

Inchi keyYCCILVSKPBXVIP-UHFFFAOYSA-N
SmilesOC1=CC=C(C=C1)CCO
SuperclassBenzenoids
ClassPhenols

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)138.166
Computed dipole moment(dipole)2.344
Total solvent accessible surface area (SASA)352.376
Hydrophobic component of SASA (FOSA)86.459
Hydrophilic component of SASA (FISA)111.477
Pie component of the SASA (PISA)154.44
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)542.429
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)2.45
Free energy of solvation of dipole (dip^2/V)0.0101286
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0098328
Globularity descriptor (glob)0.912826
Predicted polarizability in cubic angstroms (QPpolrz)14.461
Predicted hexadecane/gas partition coefficient (QPlogPC16)5.593
Predicted octanol/gas partition coefficient (QPlogPoct)8.511
Predicted water/gas partition coefficient (QPlogPw)6.836
Predicted octanol/water partition coefficient (QPlogPo/w)0.966
Predicted aqueous solubility (QPlogS)-0.97
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.434
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.679
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)868.489
Predicted brain/blood partition coefficient (QPlogBB)-0.57
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)424.778
Predicted skin permeability, log Kp (QPlogKp)-2.646
PM3 calculated ionization potential (IP(ev))9.12
PM3 calculated electron affinity (EA(eV))-0.226
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-0.576
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)85.201
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)45.72
Number of nitrogen and oxygen atoms (#NandO)2
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P00918CA2Carbonic anhydrase IIT20401SwissTargetPrediction and SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
P22748CA4Carbonic anhydrase IVT53378SEA
Q96RJ0TAAR1Trace amine-associated receptor 1 (by homology)T99524SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P03372ESR1Estrogen receptor alphaT02506SEA
P42858HTTHuntingtinT22496SEA
P14679TYRTyrosinaseT97035SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P62508ESRRGEstrogen-related receptor gammaT59875SEA
Q9Y345SLC6A5Glycine transporter 2T58937SEA
P09172DBHDopamine beta hydroxylaseT74937SEA
Q96HK3CALMCalmodulinT39610SEA
O14804TAAR5Trace amine receptor 5T60362SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20401DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P00918CA2
T20401DI0137Essential hypertension[ICD-11: BA00]P00918CA2
T20401DI0166Glaucoma[ICD-11: 9C61]P00918CA2
T20401DI0175Heart failure[ICD-11: BD10-BD1Z]P00918CA2
T20401DI0214Insomnia[ICD-11: 7A00-7A0Z]P00918CA2
T20401DI0372Seborrhoeic dermatitis[ICD-11: EA81]P00918CA2
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T99524DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]Q96RJ0TAAR1
T99524DI0149Focal/segmental autonomic disorder[ICD-11: 8D8A]Q96RJ0TAAR1
T99524DI0290Narcolepsy[ICD-11: 7A20]Q96RJ0TAAR1
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T02506DI0106COVID-19[ICD-11: 1D6Y]P03372ESR1
T22496DI0079Choreiform disorder[ICD-11: 8A01]P42858HTT
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T74937DI0175Heart failure[ICD-11: BD10-BD1Z]P09172DBH
T74937DI0341Post-traumatic stress disorder[ICD-11: 6B40]P09172DBH
T39610DI0068Cardiac arrhythmia[ICD-11: BC9Z]Q96HK3CALM
T39610DI0243Malaria[ICD-11: 1F40-1F45]Q96HK3CALM
T39610DI0370Schizophrenia[ICD-11: 6A20]Q96HK3CALM

Copyright © 2025